By: Sanchari Sinha Dutta
A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, paving the way for safer, targeted cancer therapies.
Sanchari Sinha Dutta is a feature writer for News Medical, specializing in health and medical research. With a focus on providing accurate and informative content, Sanchari covers a wide range of topics including nutrition, pharmaceutical advancements, genetic studies, and the impact of diseases on public health.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Sanchari Sinha Dutta's articles primarily focus on scientific and healthcare topics, particularly in health and medicine, nutrition, COVID-19, genetics, and medical research. Her coverage attributes indicate a heavy reliance on data with 92% citing data.
Given her focus on the scientific and healthcare fields with an emphasis on data-driven content, she would likely be interested in pitches that offer credible insights backed by robust data or studies relevant to the topics she covers. Researchers or professionals involved in cutting-edge medical research or breakthroughs may find success reaching out to her for potential coverage.
Since Sanchari focuses heavily on citing data in her articles, those who can provide access to newsworthy datasets or proprietary research findings could also capture her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .